MedTrace Logo

Renal Sympathetic Denervation by Iberis System in Patients With Uncontrolled Hypertension - Iberis-HTN Registry

NCT02295683 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2019-10-08

No results posted yet for this study

Summary

The purpose of this study is to document safety and efficacy of renal sympathetic denervation treatment in subjects with uncontrolled hypertension by using Iberis renal denervation system.

Conditions

  • Resistant Hypertension

Interventions

DEVICE

Renal Denervation

Sponsors & Collaborators

  • Terumo Europe N.V.

    lead INDUSTRY

Principal Investigators

  • José Ramon Rumoroso, Dr. · Hospital Galdakao

  • Palop López, Dr. · Hospital San Juan Alicante

  • Mauri, Dr. · Germans Trias i Pujol Hospital

  • Perez, Dr. · Hospital de Léon

  • Garcia, Dr. · Hospital Monteprincipe

  • Goicolea, Dr. · Hospital Puerta de Hierro

  • Goran Stankovic, Dr. · Clinical Center of Serbia

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2016-11-30
Completion
2017-09-04

Countries

  • Serbia
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02295683 on ClinicalTrials.gov